BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 30288321)

  • 1. Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access.
    Maponga TG; Matteau Matsha R; Morin S; Scheibe A; Swan T; Andrieux-Meyer I; Spearman CW; Klein MB; Rockstroh JK
    Hepatol Med Policy; 2017; 2():8. PubMed ID: 30288321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs.
    Day E; Broder T; Bruneau J; Cruse S; Dickie M; Fish S; Grillon C; Luhmann N; Mason K; McLean E; Trooskin S; Treloar C; Grebely J
    Int J Drug Policy; 2019 Apr; 66():87-93. PubMed ID: 30743093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
    Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
    BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of hepatitis C virus infection among people who use drugs: Ensuring equitable access to prevention, treatment, and care for all.
    Grebely J; Hajarizadeh B; Lazarus JV; Bruneau J; Treloar C;
    Int J Drug Policy; 2019 Oct; 72():1-10. PubMed ID: 31345644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus infection in HIV-exposed infants in the Western Cape, South Africa.
    Chotun N; Nel E; Cotton MF; Preiser W; Andersson MI
    Vaccine; 2015 Aug; 33(36):4618-22. PubMed ID: 26163924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Private companies: an opportunity for hepatitis B virus (HBV) prevention and care in Ivory Coast in the wake of HIV/AIDS?].
    Bekelynck A
    Bull Soc Pathol Exot; 2015 Feb; 108(1):57-62. PubMed ID: 25407333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.
    Ishizaki A; Bouscaillou J; Luhmann N; Liu S; Chua R; Walsh N; Hess S; Ivanova E; Roberts T; Easterbrook P
    BMC Infect Dis; 2017 Nov; 17(Suppl 1):696. PubMed ID: 29143609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to improve access to therapy in hepatitis B patients.
    Subic M; Zoulim F
    Liver Int; 2018 Feb; 38 Suppl 1():115-121. PubMed ID: 29427482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings.
    Said ZNA; El-Sayed MH
    World J Hepatol; 2022 Jul; 14(7):1333-1343. PubMed ID: 36158908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference.
    Papatheodoridis G; Thomas HC; Golna C; Bernardi M; Carballo M; Cornberg M; Dalekos G; Degertekin B; Dourakis S; Flisiak R; Goldberg D; Gore C; Goulis I; Hadziyannis S; Kalamitsis G; Kanavos P; Kautz A; Koskinas I; Leite BR; Malliori M; Manolakopoulos S; Matičič M; Papaevangelou V; Pirona A; Prati D; Raptopoulou-Gigi M; Reic T; Robaeys G; Schatz E; Souliotis K; Tountas Y; Wiktor S; Wilson D; Yfantopoulos J; Hatzakis A
    J Viral Hepat; 2016 Feb; 23 Suppl 1():1-12. PubMed ID: 26809941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of hepatitis C virus disease and access to hepatitis C virus services in people who inject drugs in India: a cross-sectional study.
    Solomon SS; Mehta SH; Srikrishnan AK; Solomon S; McFall AM; Laeyendecker O; Celentano DD; Iqbal SH; Anand S; Vasudevan CK; Saravanan S; Lucas GM; Kumar MS; Sulkowski MS; Quinn TC
    Lancet Infect Dis; 2015 Jan; 15(1):36-45. PubMed ID: 25486851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.
    Hatzakis A; Van Damme P; Alcorn K; Gore C; Benazzouz M; Berkane S; Buti M; Carballo M; Cortes Martins H; Deuffic-Burban S; Dominguez A; Donoghoe M; Elzouki AN; Ben-Alaya Bouafif N; Esmat G; Esteban R; Fabri M; Fenton K; Goldberg D; Goulis I; Hadjichristodoulou C; Hatzigeorgiou T; Hamouda O; Hasurdjiev S; Hughes S; Kautz A; Malik M; Manolakopoulos S; Matičič M; Papatheodoridis G; Peck R; Peterle A; Potamitis G; Prati D; Roudot-Thoraval F; Reic T; Sharara A; Shennak M; Shiha G; Shouval D; Sočan M; Thomas H; Thursz M; Tosti M; Trépo C; Vince A; Vounou E; Wiessing L; Manns M
    J Viral Hepat; 2013 Aug; 20 Suppl 2():1-20. PubMed ID: 23827008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B and HIV co-infection in pregnant women: indication for routine antenatal hepatitis B virus screening in a high HIV prevalence setting.
    Thumbiran NV; Moodley D; Parboosing R; Moodley P
    S Afr Med J; 2014 Apr; 104(4):307-9. PubMed ID: 25118561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV and Hepatitis Testing: Global Progress, Challenges, and Future Directions.
    Easterbrook P; Johnson C; Figueroa C; Baggaley R
    AIDS Rev; 2016; 18(1):3-14. PubMed ID: 26991825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.
    Leprêtre A; Ba I; Lacombe K; Maynart M; Toufik A; Ndiaye O; Kane CT; Gozlan J; Tine J; Ndoye I; Raguin G; Girard PM
    J Int AIDS Soc; 2015; 18(1):19888. PubMed ID: 26004637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for acute viral hepatitis - United States, 2007.
    Daniels D; Grytdal S; Wasley A;
    MMWR Surveill Summ; 2009 May; 58(3):1-27. PubMed ID: 19478727
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.